We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need. Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.
Combining a first-in-class, highly selective SMARCA2 degrader with an anti-PD-1 therapy may potentially enhance the anti-tumor activity of either agent because of the complementary nature of the...
WILMINGTON, Del., June 03, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will...
WILMINGTON, Del., May 09, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.25 | -4.02576489533 | 6.21 | 6.63 | 5.28 | 67529 | 5.80710215 | CS |
| 4 | 2.2 | 58.5106382979 | 3.76 | 6.72 | 3.33 | 176540 | 5.25704243 | CS |
| 12 | 2.27 | 61.5176151762 | 3.69 | 6.72 | 3.32 | 90424 | 4.76230136 | CS |
| 26 | 2.45 | 69.8005698006 | 3.51 | 6.72 | 2.62 | 76720 | 4.4322454 | CS |
| 52 | 1.92 | 47.5247524752 | 4.04 | 6.72 | 1.66 | 115663 | 3.53142377 | CS |
| 156 | -26.58 | -81.6840811309 | 32.54 | 43.5499 | 1.66 | 178391 | 11.08924501 | CS |
| 260 | -19.8 | -76.8633540373 | 25.76 | 95.375 | 1.66 | 185536 | 20.33747019 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
